ACvA’s objective to create a national strategic platform to
support academic–industry partnership was launched at its
inaugural ACvA Industry Round Table, which was held at the
Shine Dome, in Canberra with generous support by the Academy
of Science. Facilitated by Chris Hatherly, Director, Science
Policy and Projects at the Australian Academy of Science, the
Round Table was framed around two main objectives:
1) To discuss and plan how to build academic–industry
partnerships, in order to help secure the future of
cardiovascular research and,
2) To build strategies to increase and optimise all Australians’
access to medicines and evidence-based care.
The event was attended by a broad range of stakeholders—
from researchers across multiple disciplines including drug
discovery, bioengineering, clinical trials and big data,
through to clinicians and representatives from State and
Federal Departments of Health, venture capitalists, and
national heads of industry. Industry representation included
health care providers, global pharmaceutical leaders and
imaging and device companies, with over 50 participants
in total.

Click HERE to download the editorial featured in Heart, Lung, Circulation